NewLink Genetics' Series C - II Round

NewLink Genetics raised a round of funding on November 13, 2009.

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.…

Articles about NewLink Genetics' Series C - II Round: